Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683956 · ClinicalTrials.gov registry record · Phase 1
Evaluation of a Closed-Loop Control System for Administering Patient-Specific Anesthesia
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT00683956: Completed Phase 1 study, sponsored by Stanford University.
NCT00683956 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00683956, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
Numerous efforts have focused on the development of closed-loop systems to control anesthesia using the electrical activity of the brain (EEG) and EEG-based parameters as surrogate measures of anesthetic depth. New systems have been recently developed to considerably improve anesthetic control using model-based, patient-adaptive methods. The purpose of this study is to evaluate the clinical efficacy of a new intelligent software, ReinLoop, in delivering closed-loop, patient-specific hypnosis.
Interventions
- DRUG Propofol
- DEVICE ReinLoop control software for patient-specific induction and maintenance of anesthesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683956
The ClinicalTrials.gov registry entry for NCT00683956 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Propofol is the first listed.
NCT00683956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00683956 about?
NCT00683956 is a clinical study titled "Evaluation of a Closed-Loop Control System for Administering Patient-Specific Anesthesia". Numerous efforts have focused on the development of closed-loop systems to control anesthesia using the electrical activity of the brain (EEG) and EEG-based parameters as surrogate measures of anesthetic depth. New systems have been recently developed to considerably improve anesthetic control using...
What is the current status of trial NCT00683956?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2008-05. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00683956?
The interventions under investigation include: Propofol (DRUG), ReinLoop control software for patient-specific induction and maintenance of anesthesia (DEVICE).
Who is sponsoring clinical trial NCT00683956?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.